{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:25:17Z","timestamp":1791181517948,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ag activation of the BCR may play a role in the pathogenesis of human follicular lymphoma (FL) and other B cell malignancies. However, the nature of the Ag(s) recognized by tumor BCRs has not been well studied. In this study, we used unbiased approaches to demonstrate that 42 (19.35%) of 217 tested FL Igs recognized vimentin as a shared autoantigen. The epitope was localized to the N-terminal region of vimentin for all vimentin-reactive tumor Igs. We confirmed specific binding to vimentin by using recombinant vimentin and by performing competitive inhibition studies. Furthermore, using indirect immunofluorescence staining, we showed that the vimentin-reactive tumor Igs colocalized with an anti-vimentin mAb in HEp-2 cells. The reactivity to N-terminal vimentin of IgG FL Igs was significantly higher than that of IgM FL Igs (30.4 versus 10%; p = 0.0022). However, vimentin-reactive FL Igs did not share CDR3 motifs and were not homologous. Vimentin was expressed in the T cell\u2013rich regions of FL, suggesting that vimentin is available for binding with tumor BCRs within the tumor microenvironment. Vimentin was also frequently recognized by mantle cell lymphoma and multiple myeloma Igs. Our results demonstrate that vimentin is a shared autoantigen recognized by nonstereotyped FL BCRs and by the Igs of mantle cell lymphoma and multiple myeloma and suggest that vimentin may play a role in the pathogenesis of multiple B cell malignancies. These findings may lead to a better understanding of the biology and natural history of FL and other B cell malignancies.<\/jats:p>","DOI":"10.4049\/jimmunol.1300179","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T03:58:14Z","timestamp":1364443094000},"page":"4887-4898","source":"Crossref","is-referenced-by-count":58,"title":["Nonstereotyped Lymphoma B Cell Receptors Recognize Vimentin as a Shared Autoantigen"],"prefix":"10.1093","volume":"190","author":[{"given":"Soung-Chul","family":"Cha","sequence":"first","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qin","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibichakravarthy","family":"Kannan","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Rawal","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia S","family":"Watkins","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham , Birmingham, AL 35294"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio E","family":"Baio","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Ong","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kwak","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Popescu","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S","family":"Paick","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhwa","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Luong","sequence":"additional","affiliation":[{"name":"Section of Head and Neck Surgery, Department of Otorhinolaryngology, The University of Texas Medical School at Houston , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Davis","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry W","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham , Birmingham, AL 35294"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W","family":"Kwak","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S","family":"Neelapu","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"},{"name":"Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,5,1]]},"reference":[{"key":"2025032406573487300_r1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"2025032406573487300_r2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"2025032406573487300_r3","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"key":"2025032406573487300_r4","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis","volume":"203","author":"Roulland","year":"2006","journal-title":"J. Exp. Med."},{"key":"2025032406573487300_r5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jncimonographs\/lgn005","article-title":"Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals","volume":"2008","author":"D\u00f6lken","year":"2008","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"2025032406573487300_r6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"key":"2025032406573487300_r7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"2025032406573487300_r8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"2025032406573487300_r9","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood.V95.9.2922.009k38_2922_2929","article-title":"Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load","volume":"95","author":"Aarts","year":"2000","journal-title":"Blood"},{"key":"2025032406573487300_r10","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.89.15.6770","article-title":"Clonal evolution of a follicular lymphoma: evidence for antigen selection","volume":"89","author":"Bahler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032406573487300_r11","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","article-title":"Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells","volume":"108","author":"Irish","year":"2006","journal-title":"Blood"},{"key":"2025032406573487300_r12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.V78.3.581.581","article-title":"Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas","volume":"78","author":"Dighiero","year":"1991","journal-title":"Blood"},{"key":"2025032406573487300_r13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"2025032406573487300_r14","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2008.19.8903","article-title":"Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma","volume":"27","author":"Freedman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"2025032406573487300_r15","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1158\/1078-0432.CCR-04-1071","article-title":"Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen","volume":"10","author":"Neelapu","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"2025032406573487300_r16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nm1290","article-title":"Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma","volume":"11","author":"Neelapu","year":"2005","journal-title":"Nat. Med."},{"key":"2025032406573487300_r17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1705057","article-title":"Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma","volume":"36","author":"Neelapu","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"2025032406573487300_r18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/13928","article-title":"Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma","volume":"5","author":"Bendandi","year":"1999","journal-title":"Nat. Med."},{"key":"2025032406573487300_r19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(86)90032-3","article-title":"Mouse \u00d7 human heterohybridomas as fusion partners with human B cell tumors","volume":"89","author":"Carroll","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"2025032406573487300_r20","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1200\/JCO.2005.04.4289","article-title":"Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin\u2019s lymphoma resulting in durable clinical responses","volume":"24","author":"Redfern","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"2025032406573487300_r21","doi-asserted-by":"crossref","first-page":"W435","DOI":"10.1093\/nar\/gkh412","article-title":"IMGT\/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis","volume":"32","author":"Giudicelli","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"2025032406573487300_r22","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"2025032406573487300_r23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"key":"2025032406573487300_r24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.20052033","article-title":"A checkpoint for autoreactivity in human IgM+ memory B cell development","volume":"203","author":"Tsuiji","year":"2006","journal-title":"J. Exp. Med."},{"key":"2025032406573487300_r25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2003.10.007","article-title":"Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures","volume":"334","author":"Zemlin","year":"2003","journal-title":"J. Mol. Biol."},{"key":"2025032406573487300_r26","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.4049\/jimmunol.174.12.7773","article-title":"Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors","volume":"174","author":"Ivanov","year":"2005","journal-title":"J. Immunol."},{"key":"2025032406573487300_r27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"key":"2025032406573487300_r28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.bi.53.070184.003115","article-title":"Three-dimensional structure of membrane and surface proteins","volume":"53","author":"Eisenberg","year":"1984","journal-title":"Annu. Rev. Biochem."},{"key":"2025032406573487300_r29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.leu.2404426","article-title":"Molecular pathways in follicular lymphoma","volume":"21","author":"Bende","year":"2007","journal-title":"Leukemia"},{"key":"2025032406573487300_r30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herv\u00e9","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2025032406573487300_r31","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"key":"2025032406573487300_r32","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1073\/pnas.1002057107","article-title":"B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression","volume":"107","author":"Irish","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032406573487300_r33","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"key":"2025032406573487300_r34","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1172\/JCI19399","article-title":"Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia","volume":"113","author":"Ghiotto","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2025032406573487300_r35","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity","volume":"201","author":"Bende","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025032406573487300_r36","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"key":"2025032406573487300_r37","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells","volume":"103","author":"Matsui","year":"2004","journal-title":"Blood"},{"key":"2025032406573487300_r38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/ard.47.9.708","article-title":"Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus","volume":"47","author":"Blaschek","year":"1988","journal-title":"Ann. Rheum. Dis."},{"key":"2025032406573487300_r39","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2010-04-279208","article-title":"Vimentin\/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome","volume":"116","author":"Ortona","year":"2010","journal-title":"Blood"},{"key":"2025032406573487300_r40","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.1128\/MCB.24.20.9198-9206.2004","article-title":"The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature","volume":"24","author":"Xu","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2025032406573487300_r41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","article-title":"Vimentin is secreted by activated macrophages","volume":"5","author":"Mor-Vaknin","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"2025032406573487300_r42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4049\/jimmunol.176.1.652","article-title":"SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells","volume":"176","author":"Huet","year":"2006","journal-title":"J. Immunol."},{"key":"2025032406573487300_r43","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.4049\/jimmunol.177.9.6192","article-title":"Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor","volume":"177","author":"Garg","year":"2006","journal-title":"J. Immunol."},{"key":"2025032406573487300_r44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1189\/jlb.0405190","article-title":"Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis","volume":"79","author":"Moisan","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"2025032406573487300_r45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1189\/jlb.0607339","article-title":"Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor","volume":"83","author":"Leong","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"2025032406573487300_r46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/504261","article-title":"Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes","volume":"193","author":"Bryant","year":"2006","journal-title":"J. Infect. Dis."},{"key":"2025032406573487300_r47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","article-title":"Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker","volume":"350","author":"Nijenhuis","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"2025032406573487300_r48","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.yexcr.2007.03.038","article-title":"Dual roles of intermediate filaments in apoptosis","volume":"313","author":"Marceau","year":"2007","journal-title":"Exp. Cell Res."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/190\/9\/4887\/62505407\/1300179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/190\/9\/4887\/62505407\/1300179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T07:07:47Z","timestamp":1742972867000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/190\/9\/4887\/8004100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1300179","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,5]]},"published":{"date-parts":[[2013,5,1]]}}}